Specifically, punicalin has been found to inhibit LPS-induced memory impairment through anti-inflammatory and anti-amyloidogenic mechanisms by inhibiting Toll-Like Receptor-4 (TLR4)-activated NF-κB signalling [61]. This evidence concerns the gene TLR4 and memory impairment.